June 20, 2017 - By Ellis Scott
Omeros Corporation is a biopharmaceutical company. The company has market cap of $1.15 billion. The Firm is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. It currently has negative earnings. The Company’s marketed drug product, Omidria , is used during cataract surgery or intraocular lens (IOL) replacement.
Analysts expect Altaba Inc (NASDAQ:AABA) to report $0.09 EPS on July, 17.They anticipate $0.14 EPS change or 280.00% from last quarter’s $-0.05 EPS. YHOO’s profit would be $86.23 million giving it 151.28 P/E if the $0.09 EPS is correct. After having $0.06 EPS previously, Altaba Inc’s analysts see 50.00% EPS growth. The stock increased 3.58% or $1.88 during the last trading session, reaching $54.46. About shares traded. Altaba Inc (NASDAQ:AABA) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.
Ratings analysis reveals 100% of Omeros’s analysts are positive. Out of 2 Wall Street analysts rating Omeros, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $24.0 while the high is $47.0. The stock’s average target of $35.50 is 44.84% above today’s ($24.51) share price. OMER was included in 2 notes of analysts from November 10, 2016. Wedbush maintained it with “Outperform” rating and $47.0 target in Wednesday, November 16 report. The rating was maintained by Needham on Thursday, November 10 with “Buy”.
Since January 1, 0001, it had 0 insider purchases, and 2 selling transactions for $808,200 activity.
The stock increased 3.20% or $0.76 during the last trading session, reaching $24.51. About shares traded. Omeros Corporation (OMER) has risen 42.59% since June 20, 2016 and is uptrending. It has outperformed by 25.89% the S&P500.
Ingalls & Snyder Llc holds 2.77% of its portfolio in Omeros Corporation for 5.13 million shares. Cormorant Asset Management Llc owns 975,000 shares or 1.3% of their US portfolio. Moreover, American Financial Group Inc has 0.68% invested in the company for 715,101 shares. The Washington-based Lesa Sroufe & Co has invested 0.23% in the stock. Caprock Group Inc., a Idaho-based fund reported 65,934 shares.
Altaba Inc. , formerly Yahoo! Inc., is a non-diversified, closed-end management investment company. The company has market cap of $52.18 billion. The Fund seeks to track the combined investment return of the Alibaba Shares and the Yahoo Japan Shares it owns. It currently has negative earnings. Alibaba Shares represent an approximate 15% equity interest in Alibaba Group Holding Limited (Alibaba), and its Yahoo Japan Corporation ((Yahoo Japa) Shares represent an approximate 36% equity interest in Yahoo Japan.
Investors sentiment decreased to 0.72 in Q4 2016. Its down 0.16, from 0.88 in 2016Q3. It is negative, as 68 investors sold Altaba Inc shares while 207 reduced holdings. 59 funds opened positions while 139 raised stakes. 663.52 million shares or 5.16% more from 630.97 million shares in 2016Q3 were reported. 671,865 were accumulated by First Eagle Mgmt Lc. Oz Limited Partnership has 3.65M shares. Shell Asset Mngmt Com, a Netherlands-based fund reported 57,439 shares. Moreover, Claar Ltd has 7.46% invested in Altaba Inc (NASDAQ:AABA). Kanaly Tru Comm accumulated 190 shares. North Star Asset has 10,000 shares for 0.04% of their portfolio. Baldwin Brothers Ma has invested 0.01% of its portfolio in Altaba Inc (NASDAQ:AABA). Moreover, Kcg Hldg has 0.02% invested in Altaba Inc (NASDAQ:AABA). Atria Ltd owns 0.05% invested in Altaba Inc (NASDAQ:AABA) for 17,117 shares. Tarbox owns 368 shares or 0.01% of their US portfolio. Greenwich Wealth Mngmt Lc holds 2.63M shares. Hap Trading Ltd Liability Company owns 32,837 shares for 0.06% of their portfolio. Sun Life Incorporated has invested 0% of its portfolio in Altaba Inc (NASDAQ:AABA). Northern Corporation holds 0.11% of its portfolio in Altaba Inc (NASDAQ:AABA) for 9.61M shares. State Street Corporation holds 0.13% or 35.28 million shares in its portfolio.
Since December 21, 2016, it had 0 insider purchases, and 10 sales for $1.49 million activity. Utzschneider Lisa sold $20,272 worth of stock or 451 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.